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Pelvic floor rehabilitation (PFR) is an important and recommended strategy for
the treatment of many uro-gynaecological disorders including overactive bladder
(OAB), urinary incontinence (UI), chronic pelvic pain (CPP) and pelvic organ
prolapse (POP). The recognised pioneer of PFR is the American gynaecologist
Arnold Kegel who, over 60 years ago, proposed pelvic floor muscles exercises to
prevent and/or treat female UI. Kegel’s techniques were also successfully used
by other authors, but until the first International Consultation on Incontinence
(ICI) there was no scientific consensus regarding the efficacy of PFR (Monaco,
1998).
PFR consists of biofeedback (BFB), functional electrical stimulation (FES),
pelvic floor muscle training (PFMT), endovaginal or vaginal cones (VC), and
behavioural approaches. BFB allows the subject to modify the unconscious
physiological events, while FES is aimed to inhibit OAB, and improve pelvic
“awareness”, in association with pelvic floor muscles activity. PFMT plays an
extremely important role in the conservative treatment of OAB, UI and CPP, but
in the near future it should also be proposed as an actual secondary and primary
prevention of pelvic floor dysfunction. Many Authors use the rehabilitation tech-
niques according to heterogeneous protocols: the best results are obtained when
protocols requiring intensive and/or supervised PFMT are followed.
http://dx.doi.org/10.1016/j.rehab.2014.03.301
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Urodynamics is a key tool for assessment of urinary disorders in many neuro-
logical disorders. Urodynamics assess the function and dysfunction of the lower
urinary tract, trying to reproduce the patient’s complaints and provide a patho-
physiological explanation to guide therapeutics. But for each of the different
etiologies, specific questions are addressed regarding the value of urodynamic
for diagnostic, prognostic, evaluation of treatment efficacy, and follow-up.
Urodynamic in SCI is of particular importance regarding the risk for upper uri-
nary tract impairment and morbidity and mortality related to urinary disorders.
Each arm of treatment in this population requires specific evaluation and uro-
dynamic goals. Urodynamic in MS is a subject of debate in the literature and
scientific society guidelines. The place of urodynamic in this pathology will
be discussed. Urodynamic in Parkinson disease help the clinician to make the
diagnostic of Parkinson disease or multiple system atrophy. Because of the epi-
demiology, age and gender, the question of association with prolapse and benign
prostate hypertrophy is a frequent.
http://dx.doi.org/10.1016/j.rehab.2014.03.302
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Objectives.– To assess efficacy and complications of the neurogenic stress uri-
nary incontinence by adjustable continence therapy.
Patients and method.– Retrospective multicentric study with all neurologic
patients having had an adjustable continence therapy in different French uni-
versity hospitals.
Results.– From 2001 to 2013, 102 patients have been implanted. Mean ± SD
at implantation was 48.4 ± 16.5 years. The mean follow-up was 2.7 ± 2.3
years. The mean urethral closure-pressure was 33.2 ± 18.7 cm H20. The mean
maximum detrusor storage pressure was 28.5 ± 18.1 cm H20. Among patients,
3.9% were dry, 37.3% were improved 50% or greater of whom 11.8% of
patients with 90% or greater improvement, 39.2% were improved less than
50% of whom 5.9% with treatment failure. Complications were found in 74
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patients (109 balloons): 23 infected balloons, 33 migrated balloons, 21 device
failures, 26 urethral erosions, 26 cutaneous erosions. We had less migration in
spastic patients than flaccid patients (P = 0.041).
Conclusion.– Adjustable balloons continence therapy is a minimally invasive
therapy of stress urinary incontinence. It is less evaluated in population of
neurologic patients. It’s a good alternative at artificial urinary sphincter.
http://dx.doi.org/10.1016/j.rehab.2014.03.303
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Objective.– To determine the prevalence and urodynamic conditions of nocturnal
urinary disorder (NUD) in multiple sclerosis patients (MS).
Methods.– Retrospective and monocentric study conducted on 309 MS patients,
with analysis of clinical and urodynamic data. Three groups were considered:
control group (MS without NUD), nocturia group (NG), nocturnal incontinence
group (NI).
Results.– A total of 53.3% had NUD (35.7% NI). Overactive bladder symptom
score was statistically greater in NUD group (P < 0.00001). Cystomanometric
capacity and volume of first uninhibited detrusor contraction was statistically
lower in NUD (P < 0.0001) with no significant difference between NG and NI.
Discussion.– NUD is a very frequent problem in MS and overactive detrusor is
the main factor of this condition. Specific treatment of such a dysfunction may
improve quality of life of these patients and decrease the potential risk of fail
during sleep.
http://dx.doi.org/10.1016/j.rehab.2014.03.304
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Objective.– To report long-term functional outcomes of cutaneous continent
urinary diversion (CCUD) in adult neurological patients.
Methods.– Between July 2001 and January 2012, patients with a neurogenic
bladder who underwent CCUD according to Mitrofanoff’s/Monti’s/Casale’s
principle were enrolled. Stomal and urethral continence, renal function, uro-
dynamic parameters and complications were assessed.
Results.– Overall, 84 consecutive patients were included, median age 40 years
(IQR 17–76). Median follow-up time was 55 months (IQR 35–95). 95% of
patients underwent an augmentation cystoplasty. Fifty-one patients underwent a
concomitant procedure for continence. Two post-operative severe complications
(grade III–IV) were reported. Seven patients had a stoma or tube stenosis:
six were treated by dilation, one received surgery. Eight patients had blad-
der stone managed with endoscopy. Seven patients had remnant stress urine
leakage through the urethra, which was treated surgically: four received peri-
urethral balloons (ACT/Pro-ACT®), 2 a fascial sling, and 1 a tension-free vaginal
tape. Creatinine clearance had improved post-operatively in all patients. At last
follow-up, 100% of patients had a catheterizable continent stoma and urethral
continence was achieved in 91%.
Discussion.– CCUD allowed these patients to keep self-ISC as a voiding pattern
and to be continent without any appliance. Upper urinary tract was protected.
http://dx.doi.org/10.1016/j.rehab.2014.03.305
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Objective.– To report the very long-term functional results of artificial urinary
sphincter (AUS) in neurological patients.
Methods.– Neurological patients diagnosed with urinary incontinence due to
sphincter deficiency and undergoing AUS (AMS 800®) implantation between
1985 and 1992 were enrolled. Continence, defined by no pad/condom usage,
explantation and revision rates were reported.
Results.– Ten patients were included: 4 spinal cord injury, 2 spina bifida, 3
complex malformations and 1 perineal traumatism. Median age was 40 years
(IQR 29,5–42,5). Prior continence surgery was reported by 7 patients. AUS was
implanted in peribulbar(n = 5) or periprostatic position(n = 5). Median follow-up
was 15.5years (IQR 9,2–20,7). The explantation of the device due to erosion was
reported in 3 patients. The 10-, 15-, 20-year explantation-free survival rate was
87.5%. The 10-, 15-year revision-free survival rate was 28% and 0% respectively.
At last follow-up, 70% patients were continent.
Discussion.– AUS provided good functional outcomes in neurological patients
but the revision rates were important in the very long run.
http://dx.doi.org/10.1016/j.rehab.2014.03.306
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Objective.– To assess cutaneous non-continent urinary diversion with an ileal
conduit (CNCUD) in adult spina bifida patients.
Methods.– Adult spina bifida patients with a neurogenic bladder treated by
CNCUD between 1990 and 2011 in our centre were evaluated. The fol-
lowing data were collected: surgery indication, early and late postoperative
complications, renal function, stomia management.
Results.– Overall, 13 patients (9 men, 4 women) were enrolled. Median age
was 30.5years (IQR19–36,7). Median follow-up was 8.4 years (IQR1,8–10,7).
Preoperative voiding modalities were normal through the urethra (n = 5), inter-
mittent catheterization (n = 5) and indwelling catheter (n = 3).
Surgery indication was urinary incontinence associated to failure of self-
intermittent catheterization (n = 8), renal insufficiency(n = 2), vesico-cutaneous
fistulae (n = 2), cancer (n = 1).
